2/5 The Cumulative Risk of Substance Exposure and Early Life Adversity on Child Health Development and Outcomes
2/5 物质暴露和早年不幸对儿童健康发展和结果的累积风险
基本信息
- 批准号:10017367
- 负责人:
- 金额:$ 25.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-30 至 2021-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectAgeAlcohol or Other Drugs useAlcoholsAnalgesicsAreaBehavioralBiological MarkersBiometryBrainCaringChildChild AbuseChild CareChild DevelopmentChild HealthChild SupportChildhoodCognitiveCohort StudiesCommunitiesComplexConceptionsCountyDataData CollectionDevelopmentDevelopmental ProcessDrug ExposureElectroencephalographyEnsureEnvironmentEnvironmental ExposureEnvironmental Risk FactorEpidemiologyEthicsExposure toFamilyFamily StudyFamily history ofFentanylFoundationsFrightGeographic stateGovernment AgenciesGrowthHealthHealthcareHeroinHuman CharacteristicsIndividualInfantInterventionLegalLegal systemLogisticsMagnetic Resonance ImagingMarijuanaMasksMeasurementMeasuresMedical HistoryMedicineMental HealthModelingMothersNatureNeonatal Abstinence SyndromeNeurocognitiveNewborn InfantOpioidOutcomeParentsParticipantPatternPharmaceutical PreparationsPhenotypePopulationPositioning AttributePregnant WomenProcessProtocols documentationPsychometricsPublic HealthResearchRiskRuralSchoolsSeriesServicesStatistical ModelsStimulusStructureSubstance abuse problemSupport GroupsSupport SystemSystemTechniquesTestingTobaccoTranslatingVisionWorkbehavioral outcomecaregivingchild protective serviceearly life adversityearly life exposureexperiencefetalfetal opioid exposureimaging approachin uteroinnovationinterestinterpartner violencelow socioeconomic statusmultimodalitymyelinationneurodevelopmentneuroimagingopioid epidemicopioid exposureopioid usephysical conditioningrecruitrelating to nervous systemresponseskillssociodemographicsstatisticsstudy populationsynaptogenesis
项目摘要
PROJECTSUMMARY / DESCRIPTION
How do in utero opioid exposure and early adversity affect a child's neurodevelopmental and health outcomes?
The simplicity of this question masks the complex and multifaceted nature of human neurodevelopment, and the
variety of environmental influences that can exacerbate or moderate the effects of in utero substance exposure.
From conception to age 10, our brain undergoes remarkable structural and functional change. Processes
including myelination and synaptogenesis are at their peak throughout this age span, contributing to the
emergence of nearly all cognitive and behavioral skills, and responsive to both early substance exposures and
environmental stimuli. In the context of fetal opioid exposure, this often co-occurs with other maternal substance
use (alcohol, tobacco, marijuana), as well as related pre- and post-natal factors including maternal mental
health concerns, supportive or adverse family environments, low socioeconomic status (SES), inter-partner
violence, and caregiving quality and quantity. Despite increased efforts to understand the neurodevelopmental
sequela of in utero opioid and other substance exposure on long-term behavioral, cognitive, and societal
outcomes, important questions remain, specifically, 1. How is brain growth is disrupted by fetal substance and
related pre and post-natal exposures; and 2. How are these disrupted growth patterns causally related to later
cognitive and behavioral outcomes? This proposal seeks to formulate our approach to addressing these key
questions, and decipher the individual and cumulative effect of these intertwined pre- and post-natal exposures
on child neurodevelopment. By bringing together leading experts in child development and adversity, pediatric
neuroimaging, maternal, fetal, and child abuse medicine, longitudinal and functional statistics, and public health,
strategically located US states and counties hardest hit by the current opioid crisis, we will articulate our vision
of the larger HEALthy Brain & Child Development study, and lay the foundation for our participation in three
incremental steps. First, we will address the legal, ethical, and mother-child care and support concerns implicit
in this study by leveraging our team's past experience in family adversity, child abuse, and fetal substance
exposure research. Next, we will integrate across our areas of neuroimaging expertise to develop, implement,
and harmonize a multi-modal MRI and EEG protocol to assess maturing brain structure, function, and
connectivity. This neuroimaging protocol will be paired with extensive neurocognitive, sociodemographic,
physical health, family and medical history, anthropometric, and biospecimen data collection to quantify the
individual, cumulative, and interactive effects of a child's substance and environment on their overall health and
neurodevelopment. Finally, we will develop and test advanced statistical approaches to model and analyze this
multidimensional and longitudinal data, taking into account the likely sparse and unbalanced nature of the
measurements. Together, these steps lay the foundation for a broad and large-scale study to examine the
impact of exposure to substances and early adversity on a child's neural, physical, and behavioral development.
Projectsummary / Description
在子宫内阿片类药物的暴露和早期逆境如何影响儿童的神经发育和健康成果?
这个问题的简单性掩盖了人类神经发育的复杂而多方面的性质,
各种环境影响会加剧或减轻子宫内物质暴露的影响。
从概念到10岁,我们的大脑经历了显着的结构和功能变化。过程
包括髓鞘形成和突触发生在整个年龄跨度上都达到了高峰,有助于
几乎所有认知和行为技巧的出现,以及对早期物质暴露和
环境刺激。在胎儿阿片类药物暴露的背景下,这通常与其他母体物质同时发生
使用(酒精,烟草,大麻),以及相关的产前和后因素,包括母体心理
健康问题,支持性或不利的家庭环境,低社会经济地位(SES)
暴力,照料质量和数量。尽管增加了了解神经发育的努力
子宫阿片类药物和其他物质的续集在长期行为,认知和社会上暴露
结果,具体的问题仍然是1。胎儿物质和
相关的产前和产后暴露;和2。这些破坏的增长模式与以后有因果关系如何
认知和行为结果?该建议旨在制定我们解决这些关键的方法
问题,并破译这些相互交织的产前和产后暴露的个人和累积效应
关于儿童神经发育。通过汇集儿童发展和逆境领域的主要专家,儿科
神经影像学,产妇,胎儿和虐待儿童医学,纵向和功能统计以及公共卫生,
在当前的阿片类药物危机中,战略性地位于美国州和县最严重的打击,我们将阐明我们的愿景
更大的健康脑和儿童发展研究,并为我们参与三个
增量步骤。首先,我们将解决法律,道德和母子护理和支持关注的隐含
在这项研究中,通过利用我们团队过去在家庭逆境,虐待儿童和胎儿物质方面的经验
暴露研究。接下来,我们将在我们的神经影像专业知识领域融合以开发,实施,
并协调多模式MRI和EEG方案,以评估成熟的大脑结构,功能和
连接性。该神经影像学方案将与广泛的神经认知,社会人口统计学,
身体健康,家庭和病史,人体测量学和生物测定数据收集,以量化
儿童的物质和环境对他们的整体健康以及
神经发育。最后,我们将开发和测试高级统计方法,以建模和分析
考虑到多维和纵向数据,考虑到可能的稀疏和不平衡的性质
测量。这些步骤共同为一项广泛而大规模的研究奠定了基础,以检查
暴露于物质和早期逆境对儿童神经,身体和行为发展的影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Amy J Elliott其他文献
Amy J Elliott的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Amy J Elliott', 18)}}的其他基金
Maternal American-Indian Rural Community Health (MARCH)
美国-印度孕产妇农村社区健康(三月)
- 批准号:
10748656 - 财政年份:2023
- 资助金额:
$ 25.18万 - 项目类别:
South Dakota Pediatric Clinical Trials Network (SoDakPCTN)
南达科他州儿科临床试验网络 (SoDakPCTN)
- 批准号:
10923168 - 财政年份:2020
- 资助金额:
$ 25.18万 - 项目类别:
South Dakota Pediatric Clinical Trials Network (SoDakPCTN)
南达科他州儿科临床试验网络 (SoDakPCTN)
- 批准号:
10625726 - 财政年份:2020
- 资助金额:
$ 25.18万 - 项目类别:
South Dakota Pediatric Clinical Trials Network (SoDakPCTN)
南达科他州儿科临床试验网络 (SoDakPCTN)
- 批准号:
10242215 - 财政年份:2020
- 资助金额:
$ 25.18万 - 项目类别:
South Dakota Pediatric Clinical Trials Network (SoDakPCTN)
南达科他州儿科临床试验网络 (SoDakPCTN)
- 批准号:
10474477 - 财政年份:2020
- 资助金额:
$ 25.18万 - 项目类别:
South Dakota Pediatric Clinical Trials Network (SoDakPCTN)
南达科他州儿科临床试验网络 (SoDakPCTN)
- 批准号:
10064263 - 财政年份:2020
- 资助金额:
$ 25.18万 - 项目类别:
2/5 The Cumulative Risk of Substance Exposure and Early Life Adversity on Child Health Development and Outcomes
2/5 物质暴露和早年不幸对儿童健康发展和结果的累积风险
- 批准号:
10199299 - 财政年份:2019
- 资助金额:
$ 25.18万 - 项目类别:
2/5 The Cumulative Risk of Substance Exposure and Early Life Adversity on Child Health Development and Outcomes
2/5 物质暴露和早年不幸对儿童健康发展和结果的累积风险
- 批准号:
9899486 - 财政年份:2019
- 资助金额:
$ 25.18万 - 项目类别:
Environmental Influences on Child Health Outcomes in the Northern Plains Safe Passage Study Cohort
环境对北部平原安全通道研究队列儿童健康结果的影响
- 批准号:
10442792 - 财政年份:2016
- 资助金额:
$ 25.18万 - 项目类别:
相似国自然基金
基于年龄和空间的非随机混合对性传播感染影响的建模与研究
- 批准号:12301629
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
- 批准号:82373667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
母传抗体水平和疫苗初种年龄对儿童麻疹特异性抗体动态变化的影响
- 批准号:82304205
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:青年科学基金项目
随机噪声影响下具有年龄结构的布鲁氏菌病动力学行为与最优控制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
年龄结构和空间分布对艾滋病的影响:建模、分析与控制
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Executive functions in urban Hispanic/Latino youth: exposure to mixture of arsenic and pesticides during childhood
城市西班牙裔/拉丁裔青年的执行功能:童年时期接触砷和农药的混合物
- 批准号:
10751106 - 财政年份:2024
- 资助金额:
$ 25.18万 - 项目类别:
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
$ 25.18万 - 项目类别:
Fluency from Flesh to Filament: Collation, Representation, and Analysis of Multi-Scale Neuroimaging data to Characterize and Diagnose Alzheimer's Disease
从肉体到细丝的流畅性:多尺度神经影像数据的整理、表示和分析,以表征和诊断阿尔茨海默病
- 批准号:
10462257 - 财政年份:2023
- 资助金额:
$ 25.18万 - 项目类别:
Genetics of Extreme Phenotypes of OSA and Associated Upper Airway Anatomy
OSA 极端表型的遗传学及相关上呼吸道解剖学
- 批准号:
10555809 - 财政年份:2023
- 资助金额:
$ 25.18万 - 项目类别:
Identifying and Addressing the Effects of Social Media Use on Young Adults' E-Cigarette Use: A Solutions-Oriented Approach
识别和解决社交媒体使用对年轻人电子烟使用的影响:面向解决方案的方法
- 批准号:
10525098 - 财政年份:2023
- 资助金额:
$ 25.18万 - 项目类别: